Stock SIGA SIGA TECHNOLOGIES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings SIGA Technologies, Inc.

Equities

SIGA

US8269171067

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-06-11 pm EDT 		5-day change 1st Jan Change
7.86 USD +1.03% Intraday chart for SIGA Technologies, Inc. +6.07% +40.36%
Jun. 10 Sector Update: Health Care Stocks Advance Late Afternoon MT
Jun. 10 Sector Update: Health Care MT

Summary

  • From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
  • The company's Refinitiv ESG score, based on a relative ranking of the company within its sector, comes out particularly poor.

Strengths

  • Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
  • Thanks to a sound financial situation, the firm has significant leeway for investment.
  • The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.

Weaknesses

  • The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.
  • The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Pharmaceuticals

1st Jan change Capi. Investor Rating ESG Refinitiv
SIGA TECHNOLOGIES, INC. Stock SIGA Technologies, Inc.
+40.36% 553M
C-
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+48.53% 779B
C+
NOVO NORDISK A/S Stock Novo Nordisk A/S
+40.67% 631B
B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.37% 354B
C+
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.93% 333B
B-
ABBVIE INC. Stock AbbVie Inc.
+8.21% 301B
C+
ASTRAZENECA PLC Stock AstraZeneca PLC
+16.75% 249B
B+
ROCHE HOLDING AG Stock Roche Holding AG
-1.19% 216B
A+
NOVARTIS AG Stock Novartis AG
+10.85% 214B
B-
AMGEN INC. Stock Amgen Inc.
+4.40% 163B
C+
Investor Rating
Trading Rating
ESG Refinitiv

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
-
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
-
Price to Free Cash Flow
-
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
-
4m Target Price Revision
-
4m Revision of opinion
-
12m Revision of opinion
-

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality

Environment

Emissions
Innovation
Use of resources

Social

Social commitment
Human Rights
Product liability
Human Resources

Governance

CSR Strategy
Management
Shareholders

Controversy

Controversy

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. SIGA Stock
  4. Ratings SIGA Technologies, Inc.